1. Home
  2. XOS vs XLO Comparison

XOS vs XLO Comparison

Compare XOS & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOS
  • XLO
  • Stock Information
  • Founded
  • XOS 2016
  • XLO 2016
  • Country
  • XOS United States
  • XLO United States
  • Employees
  • XOS N/A
  • XLO N/A
  • Industry
  • XOS Construction/Ag Equipment/Trucks
  • XLO Biotechnology: Pharmaceutical Preparations
  • Sector
  • XOS Consumer Discretionary
  • XLO Health Care
  • Exchange
  • XOS Nasdaq
  • XLO Nasdaq
  • Market Cap
  • XOS 37.9M
  • XLO 42.1M
  • IPO Year
  • XOS N/A
  • XLO 2021
  • Fundamental
  • Price
  • XOS $3.25
  • XLO $0.90
  • Analyst Decision
  • XOS Buy
  • XLO Buy
  • Analyst Count
  • XOS 5
  • XLO 1
  • Target Price
  • XOS $10.00
  • XLO $4.00
  • AVG Volume (30 Days)
  • XOS 35.7K
  • XLO 136.9K
  • Earning Date
  • XOS 11-13-2024
  • XLO 11-07-2024
  • Dividend Yield
  • XOS N/A
  • XLO N/A
  • EPS Growth
  • XOS N/A
  • XLO N/A
  • EPS
  • XOS N/A
  • XLO N/A
  • Revenue
  • XOS $62,863,000.00
  • XLO $4,620,000.00
  • Revenue This Year
  • XOS $42.96
  • XLO N/A
  • Revenue Next Year
  • XOS $89.43
  • XLO $368.76
  • P/E Ratio
  • XOS N/A
  • XLO N/A
  • Revenue Growth
  • XOS 81.07
  • XLO N/A
  • 52 Week Low
  • XOS $3.25
  • XLO $0.49
  • 52 Week High
  • XOS $14.86
  • XLO $1.93
  • Technical
  • Relative Strength Index (RSI)
  • XOS 29.19
  • XLO 40.20
  • Support Level
  • XOS $3.50
  • XLO $0.83
  • Resistance Level
  • XOS $3.72
  • XLO $1.12
  • Average True Range (ATR)
  • XOS 0.25
  • XLO 0.09
  • MACD
  • XOS -0.04
  • XLO -0.02
  • Stochastic Oscillator
  • XOS 0.00
  • XLO 24.14

About XOS Xos Inc.

Xos Inc is an electric mobility company. It designs and develops fully electric battery mobility systems specifically for commercial fleets. The company's primary focus is on medium- and heavy-duty commercial vehicles that travel on last mile routes. The company leverages its proprietary technologies to provide commercial fleets zero emission vehicles that are easier to maintain and more cost-efficient on a total cost of ownership basis than internal combustion engine and commercial EV counterparts.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Share on Social Networks: